<DOC>
	<DOC>NCT00129220</DOC>
	<brief_summary>The purpose of this study is to confirm the efficacy of olanzapine in the treatment of manic or mixed symptoms associated with bipolar I disorder.</brief_summary>
	<brief_title>Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>Meet the criteria for manic or mixed episodes according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSMIVTR) and have a diagnosis of "294.4x Bipolar I Disorder, Most Recent Episode Manic" or "296.6x Bipolar I Disorder, Most Recent Episode Mixed". Have a total score on the Young Mania Rating Scale (YMRS) of at least 20 at Visit 1 and Visit 2. Have received an antidepressant or a psychostimulant within 5 days prior to Visit 1. The duration of the current episode is more than 90 days at Visit 1. Have a history or a diagnosis of diabetes mellitus. Have received any psychotropic medication within 2 days prior to Visit 2 (except for benzodiazepines).</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Manic or mixed episode associated with bipolar I disorder</keyword>
</DOC>